STOCK TITAN
  1. Home
  2. Sec-filings
  3. ATHE
  4. [6-K] Alterity Therapeutics Limited American Current Report (Foreign Issuer)

[6-K] Alterity Therapeutics Limited American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock ATHE logo
Alterity Therapeutics Ltd

NASDAQ:ATHE

ATHE Rankings

#7873 Ranked by Market Cap
N/A Ranked by Dividends

ATHE Latest News

Jun 23, 2025
Alterity Therapeutics to Provide Corporate Update in Fireside Chat
May 12, 2025
Alterity Therapeutics Prominently Featured at the International MSA Congress
May 7, 2025
Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress
May 5, 2025
Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy
Apr 30, 2025
Appendix 4C – Q3 FY25 Quarterly Cash Flow Report

ATHE Latest SEC Filings

Jul 14, 2025
[6-K] Alterity Therapeutics Limited American Current Report (Foreign Issuer)
Jul 7, 2025
[6-K] Alterity Therapeutics Limited American Current Report (Foreign Issuer)
Jul 3, 2025
[6-K] Alterity Therapeutics Limited American Current Report (Foreign Issuer)
Jun 30, 2025
[6-K] Alterity Therapeutics Limited American Current Report (Foreign Issuer)
Jun 23, 2025
[6-K] Alterity Therapeutics Limited American Current Report (Foreign Issuer)

ATHE Stock Data

57.59M
15.21M
1.13%
0.95%
Biotechnology
Healthcare
Link
Australia
Melbourne